Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
|
EGFR e VEGF
|
OncoTargets and Therapy |
2018 |
A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer
|
CCL5, CTNNB1, EXOSC3 e LZTR1
|
Annals of Oncology |
2018 |
STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells)
|
STAT3
|
Immunobiology |
2017 |
Application of unique sequence index (USI) barcode to gene expression profiling in gastric adenocarcinoma
|
FAT4 e CDX1
|
The Journal of Cell Communication and Signaling |
2017 |
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling
|
PAK1-STAT3/NF-κB
|
Proc Natl Acad Sci U S A |
2016 |
Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes
|
C5AR
|
Med Oncol |
2016 |
Co-expressed miRNAs in gastric adenocarcinoma
|
miRNAs 100, let-7c, 125b, 99a, 181 miRNA family e miRNA 21
|
Genomics |
2016 |
Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy
|
IL-13Rα2
|
Oncotarget |
2016 |
(A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer
|
HER2
|
Mol Diagn Ther |
2016 |
Tumor-infiltrating macrophages express interleukin-25 and predict a favorable prognosis in patients with gastric cancer after radical resection
|
IL-25
|
Oncotarget |
2016 |
Overexpression of CD39 and high tumoral CD39⁺/CD8⁺ ratio are associated with adverse prognosis in resectable gastric cancer
|
CD39 e CD8in
|
Int J Clin Exp Pathol |
2015 |
Low Expression of the bcl2 Gene in Gastric Adenocarcinomas in Mazandaran Province of Iran
|
BCL2
|
Asian Pac J Cancer Prev |
2015 |
Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma
|
Brca1, NM23, prohibitin, e spinophilin
|
Clin Cancer Res |
2013 |
MSI1 overexpression in diffuse type of gastric cancer
|
MSI1
|
Pathol Res Pract |
2013 |
Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells
|
Casp8AP2
|
Biochem Biophys Res Commun |
2012 |
CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer
|
CHIP
|
Gut |
2013 |
H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S?
|
SGC-7901
|
PLoS One |
2011 |
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells
|
miR-451
|
Clin Cancer Res |
2009 |
Tie2: a journey from normal angiogenesis to cancer and beyond
|
Tie2
|
Histol Histopathol |
2008 |
Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies
|
HER2/NEU
|
Dig Dis Sci |
2008 |
Adenovirus-mediated FasL gene transfer into human gastric carcinoma.)
|
FasL
|
World J Gastroenterol |
2005 |
Chemotherapy targeted to cancers through tumoral hormone receptors
|
LH-RH, AN-152 e AN-207
|
Trends Endocrinol Metab |
2004 |
Target Gene Mutation Profile Differs between Gastrointestinal and Endometrial Tumors with Mismatch Repair Deficiency
|
TGFβRII, Bax, IGFIIR, hMSH3, hMSH6, and GRB-14, Bat-25 e Bat-26, hMLH1
|
Cancer Res |
2002 |
No loss of sst receptors gene expression in advanced stages of colorectal cancer
|
hsst5 e hsst2 mRNA
|
Eur J Endocrinol |
1999 |
Critical factors for optimizing the 5-fluorouracil-folinic acid association in cancer chemotherapy
|
thymidylate synthase
|
Ann Oncol |
1996 |
[Comparative study of the content of 1,25-dihydroxyvitamin D3 receptors in digestive mucosa and adenocarcinoma].
|
1,25-dihydroxyvitamin D3 receptor
|
Bull Cancer |
1990 |
Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer
|
LAG3
|
Oncoimmunology |
2018 |
Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence
|
FN1 e VIM, TCF4
|
PLoS One |
2018 |
A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer
|
PI3K-AKT
|
J Gastrointest Cancer |
2019 |
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
|
MAPK e AKT-mTOR
|
Oncotarget |
2017 |
Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients
|
CCL5/CCR5
|
Journal for ImmunoTherapy of Cancer |
2016 |
Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells
|
CD133+
|
BMC Cancer |
2016 |
Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer
|
atRA
|
Immunity |
2016 |
The profile of melatonin receptors gene expression and genes associated with their activity in colorectal cancer: a preliminary report
|
GNA11, OXTR, TPH1
|
J Biol Regul Homeost Agents |
2015 |
Sphingosine kinase 2 promotes colorectal cancer cell proliferation and invasion by enhancing MYC expression.
|
SphK2
|
Tumour Biol |
2016 |
KRAS discordance between primary and recurrent tumors after radical resection of colorectal cancers
|
KRAS
|
J Surg Oncol |
2015 |
Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer
|
PTK7
|
PLoS ONE |
2015 |
Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis
|
Cathepsin B
|
Mol Carcinog |
2016 |
Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity
|
EGFR
|
Actas Dermosifiliogr |
2015 |
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
|
oxidosqualene cyclase
|
Sci Rep |
2015 |
The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer
|
VEGF
|
Eur J Surg Oncol |
2013 |
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin.
|
H1047R
|
Oncotarget |
2013 |
The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population
|
G12D
|
Genet Test Mol Biomarkers |
2013 |
Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection
|
CXCL14
|
J Transl Med |
2013 |
Production and characterization of a colon cancer-specific immunotoxin based on the fungal ribotoxin α-sarcin
|
GPA33
|
Protein Eng Des Sel |
2012 |
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
|
FOXO3a
|
Nat Med |
2012 |
AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors
|
AEZS-108
|
Expert Opin Investig Drugs |
2012 |
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target
|
TFF3
|
Int J Radiat Oncol Biol Phys |
2012 |
Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer
|
ETS
|
Virchows Arch |
2011 |
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
|
AMPK e MAPK
|
Br J Cancer |
2010 |
Down-regulation of the phosphoenolpyruvate carboxykinase gene in human colon tumors and induction by omega-3 fatty acids
|
PEPCK-C |
Biochimie |
2010 |
Endogenous expression of proteases in colon cancer cells facilitate influenza A viruses mediated oncolysis
|
Caco-2, HT-29 e SW-620
|
Cancer Biol Ther. |
2010 |
PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype
|
PTGER2
|
Cancer Epidemiol Biomarkers Prev. |
2010 |
Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
|
PXR
|
Mol Cancer |
2010 |
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
|
Nrf2
|
Oncogene |
2009 |
Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays
|
PIM1, MAPKAPK3, e ACVR2B
|
Mol Cell Proteomics |
2009 |
EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion
|
EpCAM
|
Blood |
2009 |
In vivo tumor targeting by the B-subunit of shiga toxin
|
glycosphingolipid Gb3
|
Mol Imaging |
2008 |
A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma
|
mPDGFRbeta
|
Vaccine |
2006 |
Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis
|
ANXA3, BMP4, LCN2, SPARC, MMP7, e MMP11
|
Mol Cell Proteomics |
2006 |
Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo
|
LS174T
|
Mol Cancer Ther. |
2001 |
Indomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation
|
15-PGDH
|
Prostaglandins Other Lipid Mediat |
2001 |
Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers
|
GRB-14, RHAMM, RAD50
|
Human Molecular Genetics |
2001 |
Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis
|
6TIMP2
|
Int J Cancer |
1997 |
Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data
|
Thymidylate synthase
|
Clin Cancer Res |
1997 |